Flerie AB is an active, long-term investor in the life sciences sector, specializing in biotech and pharmaceutical investments worldwide. Headquartered in Stockholm and London, Flerie manages a diversified portfolio of over 30 companies across Europe, Israel, and the US. The firm focuses on enabling pioneering companies in drug development and related services by providing resources and expertise. Flerie operates with an evergreen investment structure, allowing for sustained value creation and long-term partnerships. The company's shares are listed on Nasdaq Stockholm under the ticker 'FLERIE'.
Is Flerie Invest the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Flerie Invest, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
SEK 3,000,000 - SEK 10,000,000
When engaging Flerie AB, founders should highlight breakthrough science, robust clinical or preclinical data, and a clear path to significant medical impact. Demonstrate how your technology or platform can address unmet needs or transform current standards in biotech or pharma. Flerie values teams with deep sector expertise and a collaborative mindset, so emphasize your scientific credibility and openness to long-term partnership. Articulate how Flerie’s evergreen structure and global network can accelerate your growth and de-risk development milestones.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.